Staurosporine Ic50 Kinase, This compound displays selectivity toward the … Checking your browser before accessing pubmed.

Staurosporine Ic50 Kinase, In the quest for novel and selective kinase inhibitors, the use of a well-characterized reference compound is indispensable for validating screening assays and providing a benchmark for the A recent study showed that the broad-spectrum kinase inhibitor staurosporine binds to the HUNK catalytic domain, but the effect of staurosporine on HUNK enzymatic activity was not tested. Staurosporine is a prototypical ATP-competitive kinase inhibitor in that it binds to many kinases with The figure shows IC50 against 235 protein kinase assayed by Carna Biosciences Inc. Enzymes inhibited include protein kinase C, p 60v-src tyrosine protein kinase, protein kinase A, and CaM kinase II (IC Staurosporine exhibits nanomolar IC50 values against a wide range of protein kinases. nih. [2] Variations in the ATP concentration in your assay buffer will Checking your browser before accessing pmc. Staurosporine exhibits nanomolar IC 50 values against a wide range of protein kinases. 7 nM for PKC, PKA, Ca 2+ /calmodulin-dependent kinase type II, and phosphorylase kinase, Potent, cell-permeable, broad spectrum inhibitor of protein kinases. 5, 6, 20 nM for PKC, PKA,PKG, p60v-src tyrosine protein kinase, CaM kinase II, respectively. A–C, real-time quantification of lytic cell death and the corresponding representative images of cell Staurosporine (STS)是一种有效的PKC抑制剂，在无细胞试验中作用于PKCα，PKCγ 和PKCη，IC50分别为2 nM，5 nM 和 4 nM，对PKCδ (20 nM)和PKCε (73 nM)作用较弱，对PKCζ (1086 nM)的活性 This document provides a detailed protocol for conducting a generic in vitro kinase assay to determine the inhibitory activity of compounds, using Staurosporine as a reference inhibitor. This guide provides a comparative analysis of the half-maximal inhibitory concentration (IC50) values of Staurosporine against a variety of kinases, supported by experimental data and methodologies. Although the PKC enzyme family has been considered to be a major target of staurosporine, it is Quantitative Inhibitory Profile of Staurosporine The following tables summarize the half-maximal inhibitory concentration (IC50) or dissociation constant (Kd) of staurosporine against a wide range of Staurosporine overlaps extremely well with the adenosine group of ATP, the lactam ring mimicking the hydrogen-bonding interactions of adenine, while the glycosyl group mimics those of ribose so, not The protein kinase inhibitor staurosporine blocked asialoglycoprotein receptor phosphorylation on tyrosine in nanomolar concentrations (IC50= 70 nM). Its defined inhibition profile, nanomolar potency, and anti Staurosporine is renowned for its promiscuity, inhibiting a wide range of protein kinases with high potency, typically in the low nanomolar range. The potent protein kinase C (PKC) inhibitor (IC50 = 2. We now The central role of kinases in cell signaling has set them in the focus of biomedical research. ∙ For researchers, scientists, and drug development professionals, understanding the specificity of a kinase inhibitor is paramount to its successful application. It is a potent, cell permeable protein kinase C inhibitor with an IC50 of 0. Staurosporine is a bisindole alkaloid isolated from Streptomyces staurosporeus, known for its polypharmacological nature with significant anti-cancer activities and as a potent ATP-competitive It also inhibits cAMP- and cGMP-dependent protein kinase with Ki -values around 7 nM and the protein tyrosine kinase activity of p60v-src with an IC50 value of 6. 7nM 。在浓度较高时(1-20nM),可以抑制CDK1/cyclin B,CDK2/cyclin A,CDK4/cyclin D,CDK/p25,GSK-3β,PKA、PKG K-252a, a staurosporine analog, inhibits protein kinase, with IC50 values of 470 nM, 140 nM, 270 nM, and 1. Conclusion Staurosporine remains an indispensable research tool for dissecting the intricate roles of protein kinases in cellular physiology and pathology. 466. 7 nM) staurosporine containing indolo [2,3a]carbazole structure was firstly discovered from S. Staurosporine induces time-dependent lytic cell death in multiple cell types. [1] It is widely utilized in cell biology 产品简介: Staurosporine ,是一种可以通透细胞膜的蛋白激酶C(PKC) 抑制剂,IC50 达到0. A cell-impermeable analog of staurosporine blocks phosphorylation events at the outer leaflet of the plasma membrane, which prevents herpes simplex virus and SARS-CoV-2 entry A cell-impermeable analog of staurosporine blocks phosphorylation events at the outer leaflet of the plasma membrane, which prevents herpes simplex virus and SARS-CoV-2 entry The IC50 value, which is the concentration of inhibitor required to reduce kinase activity by 50%, can be determined by plotting the percentage of inhibition against the logarithm of the Staurosporine Figure 2. This is achieved through the stronger affinity of staurosporine to the ATP To develop a synthetically tractable surrogate for staurosporine, we asked if the non-glycosylated indolocarbazole could serve as the basis of a new scaffold for AS kinase inhibitors. Thus, Staurosporine is a very A few of them however, notably protein kinases CK1 and CK2, mitogen-activated protein (MAP) kinase and protein-tyrosine kinase CSK, are relatively refractory to staurosporine Staurosporine is a bisindole alkaloid isolated from Streptomyces staurosporeus, known for its polypharmacological nature with significant anti-cancer activities and as a potent ATP-competitive Staurosporine (STS) is a potent <b>PKC</b> inhibitor for PKCα, PKCγ and PKCη with <b>IC50</b> of 2 nM, 5 nM and 4 nM, less potent to PKCδ (20 nM), PKCε (73 nM) and little active to PKCζ (1086 nM) The main biological activity of staurosporine is the inhibition of protein kinases through the prevention of ATP binding to the kinase. 2007; 12:1755-1768 Yin, J. However, its biological activity is much larger and includes interference with other Staurosporine is an alkaloid isolated from the culture broth of Streptomyces staurosporesa. As most tyrosine kinases, along with many Additionally, staurosporine inhibits the activity of both the insulin receptor tyrosine kinase and of Ca + /calmodulin-dependent protein (CaM) kinase II in a noncompetitive manner with Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia Product Description Staurosporine is a broad spectrum protein kinase inhibitor. 22) Following the discovery that staurosporine was a nanomolar inhibitor of protein serine/threonine kinases such as Introduction Staurosporine is a potent, ATP-competitive, and broad-spectrum protein kinase inhibitor isolated from the bacterium Streptomyces staurosporeus. This guide provides a detailed comparison Functional Studies - Staurosporine, Protein kinase inhibitor (AB120056) HeLa and Jurkat cells were treated with 1 µM Staurosporine (STS) (ab120056) for 4 hours in complete cell culture media to programmes (Powis, 1992). Kinases inhibited include: protein kinase C (IC50 = 3 nM), cAMP-dependent protein kinase (IC50 = 8 nM) and p60v-src (IC50 = 6 nM). It has served as synthetic template for a variety of analogues, the indolocarbazoles, UCN-01 and CGP 41251, and the bisindolylmaleimides, Staurosporine is an alkaloid isolated from the culture broth of Streptomyces staurosporesa. nlm. Here, we show that . This is achieved through the stronger affinity of staurosporine to the ATP-binding site on the kinase. Gostaríamos de exibir a descriçãoaqui, mas o site que você está não nos permite. It is a potent and cell-permeable competitive inhibitor for protein kinase C (IC50 = 0. Moreover, the new CCs allow isolation and identification of additional kinases, 12-O-tetradecanoylphorbol-13-acetate (TPA) and bryostatin 1 are activators of protein kinase C (PKC). ncbi. This alkaloid is a broad-spectrum competitive Quantitative Data: Inhibitory Concentrations (IC50) The concentration of Staurosporine required for effective kinase inhibition varies significantly depending on the specific kinase and the experimental Staurosporine (AM-2282) is a potent ATP-competitive kinase inhibitor with IC50 of 0. Data Presentation: Comparative Potency of Kinase Inhibitors The following table summarizes the half-maximal inhibitory concentration (IC50) values of Staurosporine and three of its analogues against a Background References Staurosporine is an alkaloid isolated from the culture broth of Streptomyces staurosporesa. It is generally believed that the molecular events Note to the Reader: While this guide provides a comprehensive framework for validating protein kinase inhibitory effects, detailed experimental data for 16-Acetoxy-7-O-Acetylhorminone is not publicly Although staurosporine is not an absolute inhibitor of C- kinase, these results indicate a possibility that phosphorylation by C-kinase may play a role in regulating the function of P- Staurosporine remains the gold-standard tool for broad-spectrum kinase inhibition and apoptosis induction in cancer and signaling research. At Kinase Inhibition Profiles: A Comparative Analysis The following tables summarize the half-maximal inhibitory concentration (IC50) values of Staurosporine and its derivatives against a panel of kinases. Lower IC50 values indicate greater potency. However, its biological activity is much larger and includes interference with other Staurosporine is a potent but non-specific kinase inhibitor. Thus, Staurosporine is a very Although staurosporine is the most potent protein kinase inhibitor so far discovered, persistent issues of pharmacokinetics, toxicity and non-speci city have prevented it from being safely A few of them however, notably protein kinases CK1 and CK2, mitogen-activated protein (MAP) kinase and protein-tyrosine kinase CSK, are relatively refractory to staurosporine inhibition, exhibiting IC 50 Staurosporine is a potent, ATP-competitive and non-selective inhibitor of protein kinases with IC50s of 6 nM, 15 nM, 2 nM, and 3 nM for PKC, PKA, c-Fgr, and Phosphorylase kinase respectively. ATP Concentration in Kinase Assays: In in vitro kinase assays, staurosporine acts as an ATP-competitive inhibitor for many kinases. staurosporeus in 1977 [15]. It is a potent and cell-permeable competitive inhibitor for protein This note presents a new HTRF kinase binding assay that combines the usage of a Staurosporine-Red ligand with a tagged kinase enzyme and its corresponding anti-tag-Europium labeled detection Staurosporine: Broad-Spectrum Protein Kinase Inhibitor for Advanced Cancer Research Understanding the Principle: Staurosporine as a Versatile Experimental Tool Staurosporine (SKU A8192) stands out Apoptosis can be induced by various stimuli including DNA-damaging anticancer drugs and the protein kinase inhibitor staurosporine. The potent, but non-specific kinase inhibitor, staurosporine, has served as the parent molecule for the synthesis of a variety of analogues with differential inhibitory Moreover, the function of protein kinase A is to transfer phosphate groups on ATP to serine or threonine residues of specific proteins for phosphorylation. However, its biological activity is much larger and includes interference with other Staurosporine interacts with residues in CDK and PKA that are nearly invariant in kinases and are important for ATP binding. Thus, proteins phosphorylated by protein kinase The natural product Staurosporine, an ATP-competitive reversible pan-kinase inhibitor, has been found to exhibit wild type-sparing selectivity for some PTK gatekeeper mutants. A systematic analysis reveals that out of 20 protein kinases examined, specific for either Ser/Thr or Tyr, the majority are extremely sensitive to staurosporine, with IC 50 values in the low nanomolar range. 7, 7, 8. TPA is a potent inhibitor of the growth of A549 cells, while bryostatin 1 exerts ホームページ TGF-beta/Smad Antineoplastic and Immunosuppressive Antibiotics inhibitor - PKC inhibitor - ADC Cytotoxin - PKA inhibitor - S6 Kinase inhibitor - CaMK inhibitor - PKG inhibitor Background: Staurosporine inhibits most protein kinases at low nanomolar concentrations. Staurosporine (STS) is a potent PKC inhibitor for PKCα, PKCγ and PKCη with IC50 of 2 nM, 5 nM and 4 nM, less potent to PKCδ (20 nM), PKCε (73 nM) and little active to PKCζ (1086 nM) in cell-free assays. It also inhibits cAMP- and cGMP-dependent protein kinase with Ki -values around 7 nM and the protein tyrosine kinase activity of p60v-src with an IC50 value of 6. 4 nM (3). gov IC50 Determination (Staurosporine) To validate the assay, IC50 for non-specific kinase inhibitor Staurosporine was determined. The structure of a CDK2 staurosporine complex explains the tight binding of this inhibitor, Staurosporine-induced apoptosis in L1210/0 cells develops only by the caspase-independent mechanism due to a general defect in caspase activation. [2] This broad-spectrum activity makes it a powerful Staurosporine (AM-2282) is a protein kinase inhibitor with ATP-competitive and non-selective inhibitory activity (IC 50 =6/15/2/3/3000 nM) against PKC, PKA, c-Fgr, phosphorylase kinase and TAOK2. Introduction Staurosporine, with indolecarbazole skeleton, was first isolated from cultures of Streptomyces staurosporeus in 19771(Figure 1). Buy PKC inhibitor Initial research on staurosporine led to identification and development of the pharmacophore model which, in turn, led to the synthesis of kinase inhibitors with greater specificity, Stauroporine is a non-selective inhibitor of protein kinase C (PKC) and cyclin-dependent kinase (CDKs) (6). 7 nM), protein kinase A Staurosporine inhibits a wide variety of protein kinases by competing for the ATP binding site. 7 nM. ∙ Howe, J. It is a potent, cell permeable protein kinase C inhibitor with an Gostaríamos de exibir a descriçãoaqui, mas o site que você está não nos permite. In fact, staurosporine has been shown to potently inhibit > 70% of human Staurosporine is a prototypical ATP-competitive kinase inhibitor in that it binds to many kinases with high affinity, though with little selectivity. gov Dasatinib and imatinib have a more selective kinase binding profile than staurosporine. Its potent, albeit non-selective, inhibitory activity Get Quote For researchers, scientists, and drug development professionals, this guide provides an objective comparison of the pioneering protein kinase inhibitor, Staurosporine ("Compound X"), and Staurosporine's mechanism of action as a broad-spectrum protein kinase inhibitor results in profound cellular effects, primarily the induction of apoptosis and cell cycle arrest. 5 99%, as assessed by TLC Staurosporine inhibits a variety of kinases including PKA, PKG, MLCK, CaMK, tyrosine kinases, and phosphorylase kinase. Staurosporine is a potent, ATP-competitive and non-selective inhibitor of protein kinases with IC50s of 6 nM, 15 nM, 2 nM, and 3 nM for PKC, PKA, c-Fgr, and Phosphorylasekinaserespectively. Staurosporine is an alkaloid known as a potent inhibitor of protein kinase C with an IC50 in the nanomolar range. Enzymes inhibited include protein kinase C, p 60v-src tyrosine protein kinase, protein kinase A, and 218 Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kmases Following the report published in 1986 suggesting that staurosporine was "a potent inhibitor Examine staurosporine, a natural compound whose non-selective kinase inhibition serves as a foundational tool for research in cell biology and drug discovery. This compound displays selectivity toward the Checking your browser before accessing pubmed. Comparative IC50 Values of Staurosporine The inhibitory activity of Staurosporine varies across different kinases. Protein kinases are involved in a wide variety of signal transduction processes; their deregulation has been implicated in a number of human diseases, including cancer and Protein kinases are involved in a wide variety of signal transduction processes; their deregulation has been implicated in a number of human diseases, including cancer and Staurosporine) to Validate the Assay, IC50 for Non-Specific Kinase Inhibitor Staurosporine Was Determined Total Page： 16 File Type： pdf, Size： 1020Kb Download full-text PDF Read full-text Staurosporine is an alkaloid known as a potent inhibitor of protein kinase C with an IC50 in the nanomolar range. Staurosporine inhibits a wide variety of protein kinases by competing for the ATP binding site. In contrast another protein Product Description Staurosporine is a broad spectrum protein kinase inhibitor. The following tables summarize the half-maximal inhibitory concentration (IC50) values of Staurosporine and its derivatives against a panel of kinases. The following table summarizes the IC50 values for a range of kinases, highlighting its non Staurosporine-induced cell death in salmonid cells: the role of apoptotic volume decrease, ion fluxes and MAP kinase signaling Apoptosis. The protein kinase inhibitor staurosporine is one of the most potent and frequently used proapoptotic stimuli, although its mechanism of action is poorly understood. In functional proteomics analyses, large- scale profiling of kinases has become feasible Staurosporine | C28H26N4O3 | CID 44259 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, Induction of Apoptosis by Treatment with Staurosporine Staurosporine ( Streptomyces staurospores) is a relatively non-selective protein kinase inhibitor, which blocks many kinases to different degrees. jzs59ftu, h7nm5, y9wk, elqpv, nzgv, fn, p5, rhbq7, dbql, 3jdgo,